Skip to main content
SpringerLink
Log in
Book cover

Aging, Heart Disease, and Its Management pp 323–343Cite as

Cardiac Pacing and Defibrillators

  • Chapter

  • 126 Accesses

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

General management of pacemakers and defibrillators has been well described previously (1–3). A recent review of 2760 procedures at the Columbia—Presbyterian campus of New York Presbyterian Hospital revealed that 23% of pacemaker recipients and 5% of implantable cardioverter defibrillator (ICD) recipients were octogenarians. The 80 to 90 yr age group also accounted for 22% of pacemaker generator replacements and 5% of ICD generator replacements. The incidence of pacemaker insertion in patients older than 75 was 2.6% in a recent survey of noninstitutionalized adults. The efficacy and cost-effectiveness of pacemaker insertion in older patients are widely accepted (1), but the appropriate role for ICD insertion in the elderly remains to be established. Problems with arrhythmia control devices in older patients include difficulty with venous access, device follow-up, effects of progressive deterioration of cardiac function, dementia/delerium during and after surgery, and complex issues encompassing patient motivation, quality-of-life, and cost. This chapter will discuss general management of pacemakers as well as issues specific to older patients.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rosenheck S, Geist M, Weiss A, Hasin Y, Weiss TA, Gotsman MS. permanent cardiac pacing in octogenarians. Am J Geriatr Cardiol 1995; 4 (6): 42 - 47.

    PubMed  Google Scholar 

  2. Mond HG, Helland JR. Engineering and clinical aspects of pacing leads. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 69.

    Google Scholar 

  3. Ireland JR, Kay GN. Pulse generator circuitry. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 419.

    Google Scholar 

  4. Rodriguez F, Filimonov A, Henning A, et al. Radiation-induced effects in multiprogrammable pacemakers and implantable defibrillators. PACE 1991; 14: 2143.

    Google Scholar 

  5. Bernstein AD, Camm AJ, Fletcher R, et al. The NASPEBPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachy-arrhythmia devices. PACE 1987; 10: 794.

    Article  PubMed  CAS  Google Scholar 

  6. Wiegand UK, Potratz J, Bode F, Schreiber R, Bonnemeier H, Peters W, et al. Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block? Eur Heart J 2001; 22 (2): 174 - 180.

    Article  PubMed  CAS  Google Scholar 

  7. Sokes KB, Kay GN. Artificial electric cardiac stimulation. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 3.

    Google Scholar 

  8. Nelson SD, Kou WH, EdBuitleir M, et al. Value of programmed ventricular stimulation in presumed carotid sinus syndrome. Am J Cardiol 1987; 60: 1073.

    Article  PubMed  CAS  Google Scholar 

  9. Wharton JM, Ellenbogen KA. Atrioventricular conduction system disease. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 304.

    Google Scholar 

  10. Jaeger FJ, Fouad-Tarazi FM, Casle LW. Carotid sinus hypersensitivity and neurally mediated syncope. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 333.

    Google Scholar 

  11. Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993; 328: 1085.

    Article  PubMed  CAS  Google Scholar 

  12. Mitchell JH, Gilmore JP, Sarnoff SJ. The transport function of the atrium: factors influencing the relation between mean left atrial pressures and left ventricular end-diastolic pressure. Am J Cardiol 1962; 9: 237.

    Article  PubMed  CAS  Google Scholar 

  13. Leclercq C, Gras D, Le Hellco A, et al. Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J 1995; 129: 1133.

    Article  PubMed  CAS  Google Scholar 

  14. Prech M, Grygier M, Mitkowski P, Stanek K, Skorupski W, Moszynska B, et al. Effect of restoration of AV synchrony on stroke volume, exercise capacity, and quality-of-life: can we predict the beneficial effect of a pacemaker upgrade? Pacing Clin Electrophysiol 2001; 24 (3): 302 - 307.

    Article  PubMed  CAS  Google Scholar 

  15. Fananapazir L, Cannon RO III, Tripodi D, et al. Impact of dual-chamber permanent pacings in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to veapamil and b-adrenergic blocker therapy. Circulation 1992; 85: 2149.

    Google Scholar 

  16. Erwin JP III, Nishimura RA, Lloyd MA, Tajik AJ. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000. Mayo Clin Proc 2000; 75 (2): 173 - 180.

    PubMed  Google Scholar 

  17. Gadler F, Linde C, Daubert C, McKenna W, Meisel E, Aliot E, et al. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy. Eur Heart J 1999; 20 (14): 1044 - 1050.

    Article  PubMed  CAS  Google Scholar 

  18. Karpawich PP, Mital S. Comparative left ventricular function following atrial, septal, and apical single chamber heart pacing in the young. Pacing Clin Electrophysiol 1997; 20 (8 Pt 1): 1983 - 1988.

    Article  PubMed  CAS  Google Scholar 

  19. Leclercq C, Cazeau S, Ritter P, Alonso C, Gras D, Mabo P, et al. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000; 140 (6): 862 - 870.

    Article  PubMed  CAS  Google Scholar 

  20. Barold SS. Timing cycles and operational characteristics of pacemakers. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 567.

    Google Scholar 

  21. Lau CP, Butrous GS, Ward DE, et al. Comparison of exercise performance of six rate-adaptive right ventricular cardiac pacemakers. Am J Cardiol 1989; 63: 833.

    Article  PubMed  CAS  Google Scholar 

  22. Kay GN, Bubien RS, Epstein AE, et al. Rate-modulated cardiac pacing based on transthoracic impedance meaurements of minute ventilation: correlation with exercise gas exchange. J Am Coll Cardiol 1989; 14: 1283.

    Article  PubMed  CAS  Google Scholar 

  23. Sellers TD, Fearnot NE, Smith Hi. Temperature controlled rate-adaptive pacing. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 201.

    Google Scholar 

  24. Kay GN, Bornzin GA. Rate-modulated pacing controlled by mixed venous oxygen saturation. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 212.

    Google Scholar 

  25. Connelly DT, Rickards AF. The evoked QT potential. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 250.

    Google Scholar 

  26. Yee R, Bennett TD. Rate-adaptive pacing controlled by dynamic right ventricular pressure (dp/dtmax). In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 187.

    Google Scholar 

  27. Salo R, O’ Donoghue S, Platia EV. The use of intracardiac impedance-based indicators to optimize pacing rate. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 234.

    Google Scholar 

  28. Furman S. Rate-modulated pacing. Circulation 1990; 82: 1081.

    Article  PubMed  CAS  Google Scholar 

  29. Hesselson AB, Parsonnet B, Bernstein AD, et al. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual chamber pacing. J Am Coll Cardiol 1992; 15: 1542.

    Article  Google Scholar 

  30. Cooper MW, Smith CR, Rose EA, Schneller SJ, Spotnitz HM. Permanent transvenous pacing following orthotopic heart transplantation. J Thorac Cardiovasc Surg 1992; 104: 812 - 816.

    PubMed  CAS  Google Scholar 

  31. Magney JE, Flynn DM, Parsons JA, et al. Anatomical mechanisms explaining damage to pacemaker leads, defibrillator leads, and failure of central venous catheters adjacent to the sternoclavicular joint. PACE 1993; 16: 445.

    Article  PubMed  CAS  Google Scholar 

  32. Mond H, Sloman G. The small tined pacemaker lead-absence of dislodgement. PACE 1980; 3: 171.

    Article  PubMed  CAS  Google Scholar 

  33. Mond HG, Hua W, Wang CC. Atrial pacing leads: the clinical contribution of steroid elution. PACE 1995; 18: 1601.

    Article  PubMed  CAS  Google Scholar 

  34. Spotnitz HM. Practical considerations in pacemaker-defibrillator surgery. In: Edmunds LH Jr, ed. Cardiac Surgery in the Adult. McGraw-Hill, New York, 1997, pp. 793 - 831.

    Google Scholar 

  35. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998; 97 (18): 1796 - 1801.

    Article  PubMed  Google Scholar 

  36. Belott PH, Reynolds DW. Permanent pacemaker implantation. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995. p. 447.

    Google Scholar 

  37. Mathur G, Stables RH, Heaven D, Ingram A, Sutton R. Permanent pacemaker implantation via the femoral vein: an alternative in cases with contraindications to the pectoral approach. Europace 2001; 3 (1): 56 - 59.

    Article  PubMed  CAS  Google Scholar 

  38. Byrd CL. Recent developments in pacemaker implantation and lead retrieval. PACE 1993; 16: 1781.

    Article  PubMed  CAS  Google Scholar 

  39. Kiviniemi MS, Pirnes MA, Eranen Hi, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 1999; 22 (5): 711 - 720.

    Article  PubMed  CAS  Google Scholar 

  40. Hoyer MH, Beerman LB, Ettedgui JA, Park SC, del Nido PJ, Siewers RD. Transatrial lead placement for endocardial pacing in children. Ann Thorac Surg 1994;58(1):97-101; discussion 101-102.

    Google Scholar 

  41. Link MS, Estes NA III, Griffin JJ, Wang PJ, Maloney JD, Kirchhoffer JB, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Intery Cardiac Electrophysiol 1998; 2 (2): 175 - 179.

    Article  CAS  Google Scholar 

  42. Brewster GM, Evans AL. Displacement of pacemaker leads-a 10-year survey. Br Heart J 1979; 42: 266.

    Article  PubMed  CAS  Google Scholar 

  43. Perrins EJ, Sutton R, Kalebic B, et al. Modern atrial and ventricular leads for permanent cadiac pacing. Br Heart J 1981; 46: 196.

    Article  PubMed  CAS  Google Scholar 

  44. Aggarwal RK, Connelly DT, Ray SG, et al. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J 1995; 73: 571.

    Article  PubMed  CAS  Google Scholar 

  45. Ellenbogen KA, Stambler BS. Pacemaker syndrome. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 419.

    Google Scholar 

  46. Smith HJ, Fearnot NE, Byrd CL, et al. Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. PACE 1994; 17: 2016.

    Google Scholar 

  47. Byrd CL. Management of implant complications. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 491.

    Google Scholar 

  48. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133 (8): 604 - 608.

    PubMed  CAS  Google Scholar 

  49. Molina JE. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices.Ann Thorac Surg 1997; 63 (2): 504 - 509.

    CAS  Google Scholar 

  50. Furman S, Benedek ZM, Andrews CA, et al. Long-term follow-up of pacemaker lead systems: establishment of standards of quality. PACE 1995; 18: 271.

    Article  PubMed  CAS  Google Scholar 

  51. Mond H, Stokes KB. The electrode-tissue interface: the revolutionary role of steroid elution. PACE 1992; 15: 95.

    Article  PubMed  CAS  Google Scholar 

  52. Parsonnet V. The retention wire fix. (editorial). PACE 1995; 18: 955.

    Article  PubMed  CAS  Google Scholar 

  53. Brinker JA. Endocardial pacing leads: the good, the bad, and the ugly. (editorial; comment). PACE 1995; 18: 953.

    Article  PubMed  CAS  Google Scholar 

  54. Daoud EG, Kou W, Davidson T, et al. Evaluation and extraction of the Accufix atrial J lead. Am Heart J 1996; 131: 266.

    Article  CAS  Google Scholar 

  55. Silverman BG, Gross TP, Kaczmarek RG, et al. The epidemiology of pacemaker implantation in the United States. Public Health Rep 1995; 110: 42.

    PubMed  CAS  Google Scholar 

  56. Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 1998; 21 (9): 1730 - 1734.

    Article  PubMed  CAS  Google Scholar 

  57. Sweesy MW, Erickson SL, Crago JA, et al. Analysis of the effectiveness of in-office and transtelephonic follow-up in terms of pacemaker system complications. PACE 1994; 17: 2001.

    Google Scholar 

  58. Gessman LJ, Vielbig RE, Waspe LE, et al. Accuracy and clinical utility of transtelephonic pacemaker follow-up. PACE 1995; 18: 1032.

    Article  PubMed  CAS  Google Scholar 

  59. Goldschlager N, Ludmer P, Creamer C. Follow-up of the paced outpatient. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 780.

    Google Scholar 

  60. Aronow WS. Management of the older person with atrial fibrillation. J Am Geriatr Soc 1999; 47 (6): 740 - 748.

    PubMed  CAS  Google Scholar 

  61. Ovsyshcher IE, Katz A, Bondy C. Initial experience with a new algorithm for automatic mode switching from DDDR to DDIR mode. PACE 1994; 17: 1908.

    Article  PubMed  CAS  Google Scholar 

  62. Love CJ, Hayes DL. Evaluation of pacemaker malfunction. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 656.

    Google Scholar 

  63. Madigan JD, Choudhri AF, Chen J, Spotnitz HM, Oz MC, Edwards N. Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg 1999; 230 (5): 639 - 647.

    Article  PubMed  CAS  Google Scholar 

  64. Castle LW, Cook S. Pacemaker radiography. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 539.

    Google Scholar 

  65. Morse D, Parsonnet V, Gessman L, Droege T, Shimmel JB, Bernstein AD, et al. A Guide to Cardiac Pacemakers, Defibrillators, & Related Products. Droege Computing Services, Durham, NC, 1996.

    Google Scholar 

  66. Spotnitz HM, Ott GY, Bigger JT Jr, Steinberg JS, Livelli F Jr. Methods of implantable cardioverterdefibrillator-pacemaker insertion to avoid interactions. Ann Thorac Surg 1992; 53 (2): 253 - 257.

    Article  PubMed  CAS  Google Scholar 

  67. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342 (6): 365 - 373.

    Article  PubMed  CAS  Google Scholar 

  68. Reuter S, Garrigue S, Bordachar P, Hocini M, Jais P, Haissaguerre M, et al. Intermediate-term results of biventricular pacing in heart failure: correlation between clinical and hemodynamic data. Pacing Clin Electrophysiol 2000; 23 (11 Pt 2): 1713 - 1717.

    PubMed  CAS  Google Scholar 

  69. den Dulk K, Wellens HJJ. Antitachycardia pacing: clinical considerations. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 735.

    Google Scholar 

  70. Bonnet CA, Fogoros RN. Clinical experience with antitachycardia pacing. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical Cardiac Pacing. WB Saunders, Philadelphia, PA, 1995, p. 744.

    Google Scholar 

  71. Lauck G, von Smekal A, Wolke S, et al. Effects of nuclear magnetic resonance imaging on cardiac pacemakers. PACE 1995; 18: 1549.

    Article  PubMed  CAS  Google Scholar 

  72. Barbaro V, Bartolini P, Donato A, et al. Do European GSM mobile cellular phones pose a potential risk to pacemaker patients? PACE 1995; 18: 1218.

    Article  PubMed  CAS  Google Scholar 

  73. Brown KR, Carter W Jr, Lombardi GE. Blunt trauma-induced pacemaker failure. Ann Emerg Med 1991; 20: 905.

    Article  PubMed  CAS  Google Scholar 

  74. Epstein LM, Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Hayes DL, et al. Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation 1999; 100 (5): 516 - 525.

    Article  PubMed  CAS  Google Scholar 

  75. Manganello TD. Disabling the pacemaker: the heart-rending decision every competent patient has a right to make. Health Care Law Mon 2000; 3 - 15.

    Google Scholar 

  76. Weaver WE, Cobb LA, Hallstrom AP, et al. Factors influencing survival after out-of-hospital cardiac arrest. J Am Coll Cardiol 1986; 7: 752.

    Article  PubMed  CAS  Google Scholar 

  77. Mirowski R, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmia with an implantable automatic defibrillator in human beings. N Engl J Med 1980; 303: 322.

    Article  PubMed  CAS  Google Scholar 

  78. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverterdefibrillator. A comparison of epicardial and endocardial lead systems. Circulation 1995; 92: 59.

    Google Scholar 

  79. Shahian DM, Williamson WA, Svensson LG, et al. Transvenous versus transthoracic cardioverter-defibrillator implantation. J Thorac Cardiovasc Surg 1995; 109: 1066.

    Article  PubMed  CAS  Google Scholar 

  80. Fitzpatrick AP, Lesh MD, Epstein LM, et al. Electrophysiological laboratory, electrophysiologistimplanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation 1994; 89: 2503.

    Google Scholar 

  81. Kim SG, Roth JA, Fisher JD, et al. Long-term outcomes and modes of death of patients treated with nonthoracotomy implantable defibrillators. Am J Cardiol 1995, 75: 1229.

    Article  PubMed  CAS  Google Scholar 

  82. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335 (26): 1933 - 1940.

    Article  PubMed  CAS  Google Scholar 

  83. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576 - 1583.

    Google Scholar 

  84. Anon. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol 1999; 34 (5): 1552 - 1559.

    Google Scholar 

  85. Hohnloser SH. Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation. Am J Cardiol 1999; 84 (9A): 56R - 62R.

    Article  PubMed  CAS  Google Scholar 

  86. Klein H, Auricchio A, Reek S, Geller C. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. (Review) Am J Cardiol 1999; 83 (5B): 91D - 97D.

    PubMed  CAS  Google Scholar 

  87. Prystowsky EN, Nisam S. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol 2000; 86 (11): 1214 - 1215.

    Article  PubMed  CAS  Google Scholar 

  88. Klein HU, Reek S. The MUSTT study: evaluating testing and treatment. J Intery Cardiac Electrophysiol 2000; 4 (Suppl 1): 45 - 50.

    Article  Google Scholar 

  89. Capucci A, Aschieri D, Villani GQ. The role of EP-guided therapy in ventricular arrhythmias: betablockers, sotalol, and ICD’ s. J Intery Cardiac Electrophysiol 2000; 4 (Suppl 1): 57 - 63.

    Article  Google Scholar 

  90. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997; 337 (22): 1569 - 1575.

    Article  PubMed  Google Scholar 

  91. Block M, Breithardt G. Optimizing defibrillation through improved waveforms. PACE 1995; 18: 526.

    Article  PubMed  CAS  Google Scholar 

  92. Libero L, Lozano IF, Bocchiardo M, Marcolongo M, Sallusti L, Madrid A, et al. Comparison of defibrillation thresholds using monodirectional electrical vector versus bidirectional electrical vector. Ital Heart J 2001; 2 (6): 449 - 455.

    PubMed  CAS  Google Scholar 

  93. Horton RP, Canby RC, Roman CA, et al. Diagnosis of ICD lead failure using continuous event marker recording. PACE 1995; 18: 1331.

    Article  PubMed  CAS  Google Scholar 

  94. Luceri RM. Initial clinical experience with a dual chamber rate responsive implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2000; 23 (11 Pt 2): 1986 - 1988.

    PubMed  CAS  Google Scholar 

  95. Boineau JP, Cox JL. Slow ventricular activation in acute myocardial infarction. A source of reentrant premature ventricular contractions. Circulation 1973; 49: 702.

    Article  Google Scholar 

  96. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406 - 412.

    Google Scholar 

  97. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic cardioverter-defibrillator. J Am Coll Cardiol 1989; 13: 1353.

    Article  PubMed  CAS  Google Scholar 

  98. Spotnitz, HM. Surgical approaches to ICD insertion. In: Spotnitz HM, ed. Research Frontiers in Implantable Defibrillator Surgery. RG Landes, Austin, TX, 1992, p. 23.

    Google Scholar 

  99. Watkins L Jr, Taylor E Jr. Surgical aspects of automatic implantable cardioverter-defibrillator implantation. PACE 1991; 14: 953.

    Article  PubMed  Google Scholar 

  100. Auteri JS, Jeevanandam V, Bielefeld MR, et al. Effects of location of AICD patch electrodes on the left ventricular diastolic pressure-volume curve in pigs. Ann Thorac Surg 1991; 52: 1052.

    Article  PubMed  CAS  Google Scholar 

  101. Barrington WW, Deligonul U, Easley AR, Windle JR. Defibrillator patch electrode constriction: an underrecognized entity. Ann Thorac Surg 1995; 60: 1112.

    Article  PubMed  CAS  Google Scholar 

  102. Spotnitz HM. Effects of ICD insertion on cardiac function. In: Spotnitz HM, ed. Research Frontiers in Implantable Defibrillator Surgery. RG Landes, Austin, TX, 1992, p. 98.

    Google Scholar 

  103. Park WM, Amirhamzeh MMR, Bielefeld MR, et al. Systolic arterial pressure recovery after ventricular fibrillation/flutter in humans. PACE 1994; 17: 1100.

    Article  PubMed  CAS  Google Scholar 

  104. Hauser RG, Kurschinski DT, McVeigh K, et al. Clinical results with nonthoracotomy 1CD systems. PACE 1993; 16: 141.

    Article  PubMed  CAS  Google Scholar 

  105. Mattke S, Muller D, Markewitz A, et al. Failures of epicardial and transvenous leads for implantable cardioverter defibrillators. Am Heart J 1995; 130: 1040.

    Article  PubMed  CAS  Google Scholar 

  106. Roelke M, O’Nunain, Osswald S, et al. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. PACE 1995; 18: 973.

    Google Scholar 

  107. Argenziano M, Spotnitz HM, Goldstein DJ, Weinberg AD, Dizon JM, Bigger JT Jr. Longevity of lead systems in patients with implantable cardioverter-defibrillators. Circulation 2000; 102: I1 - 397.

    Google Scholar 

  108. Jones GK, Bardy GH, Kudenchuk PJ, et al. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future systems design. Am Heart J 1995; 130 - 327.

    Google Scholar 

  109. Dean DA, Livelli FL Jr, Bigger JT Jr, Spotnitz HM. Safe repair of insulation defects in ICD leads. PACE 1996; 19: 678 (abstract).

    Google Scholar 

  110. Jeevanandam V, Bielefeld MR, Auteri JS, et al. The implantable defibrillator: an electronic bridge to cardiac transplantation. Circulation 1992; 86: II - 276.

    Google Scholar 

  111. Bolling SF. Implantable cardioverter-defibrillators as a bridge to cardiac transplantation. In: Spotnitz HM, ed. Research Frontiers in Implantable Defibrillator Surgery. RG Landes, Austin, TX, 1992, p. 57.

    Google Scholar 

  112. May CD, Smith PR, Murdock CL, Davis MJE. The impact of implantable cardioverter defibrillator on quality-of-life. PACE 1995; 18: 1411.

    Article  PubMed  CAS  Google Scholar 

  113. Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients’ attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol 2000; 23 (6): 934 - 938.

    Article  PubMed  CAS  Google Scholar 

  114. Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients’ long-term adjustment to the ICD: a prospective study. Pacing Clin Electrophysiol 2000; 23 (4 Pt 1): 450 - 456.

    Article  PubMed  CAS  Google Scholar 

  115. Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med 2001; 345 (6): 391 - 397.

    Article  PubMed  CAS  Google Scholar 

  116. Hoffmaster B. The ethics of setting limits on ICD therapy. Can J Cardiol 2000; 16 (10): 1313 - 1318.

    PubMed  CAS  Google Scholar 

  117. Stanton MS, Bell GK. Economic outcomes of implantable cardioverter-defibrillators. Circulation 2000; 101 (9): 1067 - 1074.

    Article  PubMed  CAS  Google Scholar 

  118. O’Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation 2001; 103 (10): 1416 - 1421.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Henry M. Spotnitz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Niloo M. Edwards MD

  2. Division of Circulatory Physiology/Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Mathew S. Maurer MD

  3. University of Connecticut School of Medicine, Farmington, CT, USA

    Rachel B. Wellner BA, MPH

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Spotnitz, H.M. (2003). Cardiac Pacing and Defibrillators. In: Edwards, N.M., Maurer, M.S., Wellner, R.B. (eds) Aging, Heart Disease, and Its Management. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-357-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-357-6_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9766-3

  • Online ISBN: 978-1-59259-357-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation